Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KAT8 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | KDM5B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | NUBP2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | MARCH2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | KRTAP19-5 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | TM2D2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | ALKBH3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | RB1CC1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ZNF404 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | TNKS2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |